On February 7, 2024, Anand Reddi resigned from the Board of Directors of Hepion Pharmaceuticals, Inc. (Company). Mr. Reddi was Chairman of the company?s Compensation Committee and a member of the Corporate Governance/Nominations Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 USD | -2.56% | -8.06% | -64.81% |
May. 21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.81% | 6.4M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- HEPA Stock
- News Hepion Pharmaceuticals, Inc.
- Hepion Pharmaceuticals, Inc. Announces Resignation of Anand Reddi from the Board of Directors